EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

SRS 16‐86 promotes diabetic nephropathy recovery by regulating ferroptosis

Yingchun Qiao, Chao Sun iD, Shunli Kan, Lu He, Yawen Wang, Huajun Gao, Yingying Zhang, You Cheng, Shuai Wang, Long Zhao, Wenyan Niu

Experimental Physiology · 2024

DOI: 10.1113/ep091520 ↗

At a glance

Journal article in Experimental Physiology, 2024. Written by Yingchun Qiao and 10 co-authors. Institution: NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Clinical Laboratory, Chu Hsien-I Memorial…. Major MEDLINE topics: Ferroptosis, Diabetic Nephropathies, Rats, Sprague-Dawley, Diabetes Mellitus, Experimental. Cited 6 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital, Funding of Tianjin Educational Committee, Funding of Tianjin Health Research Project.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM), and cell death plays an important role. Ferroptosis is a recently discovered type of iron‐dependent cell death and one that is different from other kinds of cell death including apoptosis and necrosis. However, ferroptosis has not been described in the context of DN. This study explored the role of ferroptosis in DN pathophysiology and aimed to confirm the efficacy of the ferroptosis inhibitor SRS 16‐86 on DN. Streptozotocin injection was used to establish the DM and DN animal models. To investigate the presence or occurrence of ferroptosis in DN, we assessed the concentrations of iron, reactive oxygen species and specific markers associated with ferroptosis in a rat model of DN. Additionally, we performed haematoxylin–eosin staining, blood biochemistry, urine biochemistry and kidney function analysis to evaluate the efficacy of the ferroptosis inhibitor SRS 16‐86 in ameliorating DN. We found that SRS 16‐86 could improve the recovery of renal function after DN by upregulating glutathione peroxidase 4, glutathione and system x c − light chain and by downregulating the lipid peroxidation markers and 4‐hydroxynonenal. SRS 16‐86 treatment could improve renal organization after DN. The inflammatory cytokines interleukin 1β and tumour necrosis factor α and intercellular adhesion molecule 1 were significantly decreased following SRS 16‐86 treatment after DN. The results indicate that there is a strong connection between ferroptosis and the pathological mechanism of DN. The efficacy of the ferroptosis inhibitor SRS 16‐86 in DN repair supports its use as a new therapeutic treatment for DN.

Subjects

MeSH terms (MEDLINE)

FerroptosisDiabetic NephropathiesRats, Sprague-DawleyDiabetes Mellitus, ExperimentalAnimalsMaleRatsReactive Oxygen SpeciesLipid PeroxidationKidneyIron

Author keywords

diabetic nephropathyferroptosisferroptosis inhibitor

Substances

Reactive Oxygen SpeciesIron

Authors and institutions

  • NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Clinical Laboratory, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical Univer…
  • International Science and Technology Cooperation Base of Spinal Cord Injury, Tianjin Key Laboratory of Spine and Spinal Cord Injury, Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin Medica…
  • Department of Spine Surgery, Tianjin Union Medical Center, Tianjin, China.

ORCID profiles: Chao Sun

Funding

  • Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital
  • Funding of Tianjin Educational Committee
  • Funding of Tianjin Health Research Project

Cite

APA

Qiao, Y., Sun, C., Kan, S., He, L., Wang, Y., Gao, H., Zhang, Y., Cheng, Y., Wang, S., Zhao, L., & Niu, W. (2024). SRS 16‐86 promotes diabetic nephropathy recovery by regulating ferroptosis. Experimental Physiology. https://doi.org/10.1113/ep091520

Vancouver

Qiao Y, Sun C, Kan S, He L, Wang Y, Gao H, et al. SRS 16‐86 promotes diabetic nephropathy recovery by regulating ferroptosis. Experimental Physiology. 2024. doi:10.1113/ep091520

BibTeX
@article{Qiao2024,
  author = {Qiao, Yingchun and Sun, Chao and Kan, Shunli and He, Lu and Wang, Yawen and Gao, Huajun and Zhang, Yingying and Cheng, You and Wang, Shuai and Zhao, Long and Niu, Wenyan},
  title = {SRS 16‐86 promotes diabetic nephropathy recovery by regulating ferroptosis},
  journal = {Experimental Physiology},
  year = {2024},
  doi = {10.1113/ep091520}
}
Start for free →